During the past decade, Gastro Campus Research GbR conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 6 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 6 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Gastro Campus Research GbR" are "Crohn's Disease" (5 trials), "Ulcerative Colitis" (3 trials), "Colitis, Ulcerative" (1 trials) and "Crohn Disease" (1 trials). Many other conditions were trialed in "Gastro Campus Research GbR" in a lesser frequency.

Most popular intervention types in "Gastro Campus Research GbR" are "Drug" (8 trials), "Other" (5 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Ontamalimab" (4 trials), "GED-0301" (2 trials), "Golimumab" (2 trials) and "Guselkumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Gastro Campus Research GbR" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Gastro Campus Research GbR". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Gastro Campus Research GbR, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Gastro Campus Research GbR, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".